SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • November 8th, 2018 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Michigan
Contract Type FiledNovember 8th, 2018 Company Industry JurisdictionTHIS SEPARATION AND RELEASE AGREEMENT (this “Agreement”) is made as of September 21, 2018 by and between GEMPHIRE THERAPEUTICS INC., a Delaware corporation, whose address is 17199 N. Laurel Park Drive, Suite 401, Livonia, Michigan 48152 (the “Company”) and LEE GOLDEN whose address is as reflected in the personnel records of the Company (“Employee”). Capitalized terms used but not defined in this Agreement will have the meanings ascribed to them in the Employment Agreement between Employee and the Company dated September 6, 2016 (the “Employment Agreement”).
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • November 8th, 2018 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Michigan
Contract Type FiledNovember 8th, 2018 Company Industry JurisdictionTHIS SEPARATION AND RELEASE AGREEMENT (this “Agreement”) is made as of September 21, 2018 by and between GEMPHIRE THERAPEUTICS INC., a Delaware corporation, whose address is 17199 N. Laurel Park Drive, Suite 401, Livonia, Michigan 48152 (the “Company”) and JEFFREY S. MATHIESEN whose address is as reflected in the personnel records of the Company (“Employee”). Capitalized terms used but not defined in this Agreement will have the meanings ascribed to them in the Employment Agreement between Employee and the Company dated April 14, 2016 (the “Employment Agreement”).